Novel inhaled combination powders containing colistin with enhanced antimicrobial activities on both planktonic cell and biofilm of pseudomonas aeruginosa
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: ZHOU, Qi (Tony) (The University of Sydney, Faculty of Pharmacy, Sydney, Australia)
- Co-author(s): Sun, Si-Ping (The University of Sydney, Sydney, Australia)
Barraud, Nicolas (University of New South Wales, Sydney, Australia)
Li, Jian (Monash University, Melbourne, Australia)
Chan, Hak-Kim (The University of Sydney, Sydney, Australia)
Background. Colistin is the last-resort antibiotic for the respiratory infections caused by multidrug resistant bacteria despite its severe nephrotoxicity.
Aims. This study aims to develop a new powder formulation of colistin combination with enhanced antimicrobial activities.
Methods. 16 formulations were prepared consisting of colistin,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.